Spore-based probiotics are supplements made from Bacillus bacteria packaged as dormant spores, a tough form that survives stomach acid and then germinates in the small intestine[1][2]. Some named strains have solid trial evidence, such as Bacillus clausii for acute diarrhea in children[3]. Others have little, and product quality varies widely.
The benefits are strain-specific, not a property of "spores" in general[4]. Below: what spore and soil-based probiotics are, how they behave in the gut, what the trials show, how they compare with regular probiotics, and the safety questions that make them controversial.
What are spore-based probiotics?
A probiotic is a live microorganism that, given in adequate amounts, confers a health benefit on the host[5]. Spore-based probiotics meet that definition using bacteria that can switch into an endospore: a dormant cell that resists heat and survives the gastric barrier of the upper digestive tract[1]. This is why they are sold in capsules that need no refrigeration, and why they are also used in animal feed and in registered medicines[1].
Nearly every product uses species from the genus Bacillus (sometimes sold as "sporebiotics"). These are the ones you will see on labels, and what has actually been studied:
| Species | Strains in human studies | What was studied | Evidence level |
|---|---|---|---|
| Bacillus coagulans | Unique IS2, MTCC 5856, BC300 | IBS symptoms, constipation | Meta-analyses plus RCTs[6][7] |
| Bacillus clausii | O/C, N/R, SIN, T (four-strain mix) | Acute diarrhea in children, antibiotic-associated diarrhea | Meta-analysis of 6 RCTs; systematic review[3][8] |
| Bacillus subtilis | DE111, CU1, C-3102 | Germination in the gut, immune markers, digestion | Small RCTs; inconsistent results[9][10] |
| Bacillus licheniformis | Usually in blends | Endotoxin markers (as part of a blend) | One small RCT; rare infection reports[11][12] |
| Bacillus indicus | Usually in blends | Endotoxin markers (as part of a blend) | One small RCT[11] |
| Bacillus cereus | Some products sold in China | Product safety testing | Toxin genes found; a food-poisoning species[13] |
The strain code after the species name matters. Two products listing "Bacillus subtilis" can contain strains with different effects in trials[9]. Not every popular probiotic is spore-based, either: the label of Seed's DS-01, which we retrieved in October 2026, lists no Bacillus strains[14] (our Seed probiotics review covers its trials).
Are soil-based probiotics the same as spore-based probiotics?
In practice, yes: "soil-based probiotics" and "soil-based organisms (SBOs)" are marketing names for the same Bacillus spore products. The label reflects the old view that these bacteria live mainly in soil.
Researchers who study them argue that view is misplaced. A review in Food Microbiology concluded that Bacilli should be considered gut commensals rather than soil organisms[1]. Bacillus subtilis has been isolated from human ileum biopsies and stool, and those isolates could form biofilms, sporulate without oxygen and secrete antimicrobial compounds, all traits suited to gut life[15].
So "soil-based" describes where the idea came from, not whether a product works. Judge a product by its species, strain code and the trials behind that strain[4].
How do spore-based probiotics work in the gut?
Spores pass the stomach intact, wake up (germinate) in the small intestine, act for a few days, and then most are cleared[2][16]. Two human studies show the timeline:
- Germination within hours. In 11 people with ileostomies, B. subtilis DE111 spores appeared in fluid from the end of the small intestine 3 hours after a dose. Active (vegetative) cells reached about 73 million CFU per gram at 7 hours, which means the spores survived the stomach and germinated in the small intestine[2].
- Transient presence. In three kinetics studies in healthy volunteers (22, 22 and 30 people), B. clausii spores were tracked in stool for up to the 8th day after dosing, with high variability between people[16].
In mice, B. subtilis spores germinated, grew and formed new spores inside the gut. Biofilm-forming natural strains persisted longer than a lab strain[17]. That suggests some strains can complete a life cycle in the gut, but it has not been shown to mean lasting colonization in people.
How they might help is still being worked out. Proposed mechanisms include antimicrobial secretion and immune signalling, and reviews note that results differ between strains and studies[15][9].
Do spore-based probiotics work? What the trials show
Some strains do, for specific problems. The strongest evidence is for B. clausii in children's acute diarrhea and for certain B. coagulans strains in irritable bowel syndrome (IBS)[3][4]. For most other claims, the trials are small, use surrogate markers or are funded by manufacturers.
| Use | Strain | Study | Result |
|---|---|---|---|
| Acute diarrhea in children | B. clausii (4 strains) | Meta-analysis, 6 RCTs, 1,298 children | Diarrhea about 9 hours shorter; hospital stay 0.85 days shorter[3] |
| Antibiotic-associated diarrhea | B. clausii (O/C, N/R, SIN, T) | Systematic review, 4 studies | Lower risk of diarrhea and GI symptoms during antibiotics[8] |
| IBS abdominal pain | B. coagulans MTCC 5856, Unique IS2 | Network meta-analysis, 81 RCTs, 9,253 adults | Among the top-ranked probiotics for pain[6] |
| IBS symptoms | B. coagulans Unique IS2 | Strain-specific meta-analysis | Improved key IBS symptoms vs placebo[4] |
| IBS symptoms | B. coagulans BC300 | RCT, 123 adults | No difference at 12 weeks; better at week-16 follow-up[18] |
| Functional constipation | B. coagulans Unique IS2, 2 billion CFU/day | RCT, 100 adults, 4 weeks | More bowel movements; normal stools in 98% vs 74% on placebo[7] |
| Post-meal endotoxin | Commercial Bacillus blend | RCT, healthy adults, 30 days | 42% less post-meal endotoxin, 24% lower triglycerides[11] |
| Winter infections in older adults | B. subtilis CU1 | RCT, 100 adults aged 60-74 | No significant drop in sick days; higher secretory IgA[10] |
Digestive symptoms: IBS and constipation
In a network meta-analysis of 81 IBS trials, two B. coagulans strains ranked among the most effective probiotics for abdominal pain. The authors stressed that only some probiotics help with particular outcomes[6].
A 2026 analysis limited to single-strain, placebo-controlled trials confirmed benefit for Unique IS2. It also found quality-of-life gains for MTCC 5856[4].
Results are not uniform. In a three-arm trial, B. coagulans BC300 did no better than placebo during 12 weeks of treatment, though more people improved by the week-16 follow-up (52.9% vs 20.5%)[18].
For constipation, one 100-person trial of Unique IS2 found more frequent stools and less straining and pain[7]. Our guides to probiotic strains for IBS and probiotics for constipation compare these with non-spore strains.
Diarrhea, including during antibiotics
Across 6 randomized trials in children with acute diarrhea, B. clausii shortened diarrhea by 9.12 hours (95% CI 1.75 to 16.49) and hospital stays by 0.85 days[3]. For antibiotic-associated diarrhea, a 2025 review found lower risk with doses of 4 billion CFU a day in children and 6 billion in adolescents and adults, for up to 14 days[8]. Both reviews involved authors employed or funded by the product's manufacturer, Sanofi[3][8].
Gut barrier, endotoxin and immunity
The "leaky gut" claims on spore products trace largely to one industry-funded trial. In it, healthy adults with a large post-meal rise in endotoxin (LPS) took a commercial Bacillus spore blend or rice-flour placebo for 30 days. Post-meal endotoxin fell 42% on the spores and rose 36% on placebo[11]. These are lab markers in one small trial, not evidence that the product treats leaky gut or any disease.
For the immune system, B. subtilis CU1 missed its main goal in older adults: 5.1 vs 6.6 days of infection symptoms over 4 months, not a significant difference. It did raise secretory IgA in stool and saliva in a subgroup[10].
Are spore probiotics better than regular probiotics?
Not in general. Spores survive heat and stomach acid better than traditional probiotics, but survival is not the same as benefit[1]. The 2026 strain-specific meta-analysis found effective strains in both camps: Lactobacillus rhamnosus GG, Lactiplantibacillus plantarum 299v and Bifidobacterium longum 35624 alongside B. coagulans Unique IS2[4]. It also found several well-known strains that did not beat placebo[4].
| Spore-based (Bacillus) | Conventional (Lactobacillus, Bifidobacterium) | |
|---|---|---|
| Heat and stomach acid | Spores are heat-stable and survive the gastric barrier[1] | Less resistant than spores, which is the spores' main selling point[1] |
| Time in the gut | Measurable in stool for about a week after dosing (B. clausii)[16] | Not compared in the studies we reviewed |
| Best evidence | Children's acute diarrhea; IBS for named B. coagulans strains[3][6] | IBS for several named strains[4] |
| Main safety questions | Product purity, toxin genes, antibiotic resistance[19] | Rare bloodstream infections in very ill patients[20] |
If a specific strain has a trial for your problem, that matters more than whether it is a spore[4].
For a broader comparison of what is sold, see our best probiotics guide, our picks of probiotics for men, and our look at next-generation probiotics. The difference between prebiotic and probiotic products is covered separately.
Are spore-based probiotics safe? Why they are controversial
Well-characterized strains have been well tolerated in trials, but the category has real quality and safety issues[3][19]. Most of the controversy is about what is actually in the bottle and who should avoid these products.
What is actually in the bottle
Independent lab testing has repeatedly found problems:
- A study of five commercial Bacillus products found four were mislabeled and four showed high levels of antibiotic resistance[21].
- In 50 probiotic products bought in China, 56% contained bacteria not listed on the label. Of 48 Bacillus isolates, 28 were B. cereus, and 58% carried genes for the Nhe enterotoxin[19].
- In 15 probiotic B. cereus preparations, most were mislabeled and every B. cereus-group strain isolated (B. cereus and Bacillus thuringiensis) produced enterotoxin. In one strain, a tetracycline-resistance gene could transfer to other bacteria[13].
In the EU, Bacillus species used in regulated food and feed products must show an absence of toxigenic potential, and strains should not carry acquired resistance genes to clinically relevant antibiotics. EFSA also notes that human probiotic supplements are generally not assessed this way unless they are a novel food[22].
Who should be cautious
Infections from probiotic Bacillus are rare but documented, almost always in very sick people:
- Among 16,436 children after cardiac surgery, 5,034 received probiotics and 6 developed bacteremia with probiotic strains, including B. subtilis and B. licheniformis. All had central venous lines, three had not been given probiotics themselves, and all cleared the infection with antibiotics[20].
- Two patients developed B. licheniformis bloodstream infections after oral probiotics given for gastrointestinal bleeding. The authors advised caution in people who are immunocompromised or have severe damage to the gut lining[12].
If you are immunocompromised, have a central line, are critically ill, or have a serious bowel condition, talk to your clinician before taking any spore probiotic.
What are the side effects of spore probiotics?
In controlled trials of named strains, side effects were similar to placebo. B. coagulans BC300 showed no difference in adverse events versus placebo over 12 weeks[18].
B. clausii was well tolerated across formulations in healthy volunteers[16], and the pediatric meta-analysis reported a good safety profile[3].
How to choose and take a spore probiotic
Comparing spore based probiotics brands? These steps matter more than the brand name.
- Find the strain code. Look for a code after the species name (for example "B. coagulans Unique IS2"). A label that lists only species gives you nothing to check against trials[9].
- Match it to a trial for your problem. Use the evidence table above. A strain studied for children's diarrhea is not evidence for bloating or immunity.
- Compare the dose with what studies used. Studies used 2 billion CFU a day of B. coagulans Unique IS2 for constipation[7], 4 to 6 billion CFU a day of B. clausii during antibiotics[8], and 2 billion B. subtilis CU1 spores a day in 10-day courses[10]. Our CFU guide explains label counts.
- Take it daily, at a time you will remember. Spores are cleared within about a week[16], and no trial we found compared times of day. See when to take probiotics.
- Give it the trial's timeframe, then reassess. The trials above ran 4 to 12 weeks[7][18]. If nothing changes in that window, that product may not be the right fit for you.
- Avoid products that list B. cereus. It is a food-poisoning species, and probiotic preparations of it have carried toxin and transferable resistance genes[13].
This article is for general educational purposes and is not medical advice. Spore-based probiotics are sold as supplements, and their quality and strain content vary by product. Talk to a qualified healthcare professional before starting a probiotic, particularly if you are pregnant, immunocompromised, taking prescription medication, or managing a diagnosed condition.
Frequently Asked Questions
What does MegaSporeBiotic do?
MegaSporeBiotic is a Bacillus spore supplement from Microbiome Labs. The best-known human trial of a commercial spore blend, funded in part by a Microbiome Labs grant, enrolled healthy adults whose blood endotoxin rose sharply after a high-fat meal. After 30 days, the spore group had 42% less post-meal endotoxin and 24% lower post-meal triglycerides, while the placebo group's endotoxin rose 36%. The study was small, industry-funded and measured lab markers rather than symptoms or disease, so it cannot show that the product treats any condition.
Can you take spore probiotics with antibiotics?
Some can. A 2025 systematic review describes the four Bacillus clausii strains in Enterogermina (O/C, N/R, SIN, T) as resistant to most commonly used antibiotics, and the studies it pooled gave them during antibiotic courses to reduce antibiotic-associated diarrhea. That resistance is a property of those characterized strains, not a safety feature of every spore product: in a lab survey of 48 Bacillus isolates from commercial probiotics, all resisted lincomycin and 5 resisted tetracycline, and the authors called for closer surveillance of resistance genes. Ask your prescriber before adding any supplement to an antibiotic course.
Do spore-based probiotics help SIBO?
There is no good trial evidence yet. In our PubMed searches in October 2026 we found no randomized controlled trial testing a spore-based probiotic as a treatment for small intestinal bacterial overgrowth, despite heavy online discussion of the idea. Claims that spores suit SIBO better than other probiotics are, for now, untested in controlled trials. If you have or suspect SIBO, see our SIBO overview and discuss any probiotic with the clinician treating you.
When is the best time to take spore-based probiotics?
No trial has compared morning and evening dosing of spore probiotics, so consistency matters more than the hour. Spores are built to survive stomach acid, and in one study Bacillus subtilis DE111 spores reached the small intestine and began germinating within 3 hours of a dose. Because ingested Bacillus clausii spores were measurable in stool for only about a week after dosing, the trials that showed benefits gave the product every day for the whole study period.
Do spore probiotics permanently colonize your gut?
The human data point the other way. In three kinetics studies in healthy volunteers, Bacillus clausii spores showed up in stool for about 8 days after dosing and then fell away, which is why most researchers describe these strains as transient. Mouse work shows Bacillus subtilis can germinate, grow and form new spores inside the gut, and some natural isolates stay longer than lab strains, but that is not the same as permanent colonization in people.
Are Seed probiotics spore-based?
No. The label for Seed's DS-01 Daily Synbiotic that we retrieved from the manufacturer's site in October 2026 lists strains of Lactobacillus and related genera, Bifidobacterium and Streptococcus thermophilus, counted in AFU, and no Bacillus or other spore-forming species. Spore-based products name Bacillus species such as B. coagulans, B. subtilis or B. clausii on the label, so the ingredient list is the quickest way to tell which type you are holding.
What is an example of a bacterial spore?
The best-known example is the endospore of Bacillus subtilis: a dormant, dehydrated copy of the cell wrapped in protective layers that lets it survive heat, drying and stomach acid, then germinate when conditions improve. Probiotic spores of B. coagulans and B. clausii work the same way. Not all spores are harmless: Bacillus cereus forms spores too, and it is a known cause of food poisoning, which is why it does not belong in a probiotic.
Can I take Bacillus coagulans daily?
The trials of named Bacillus coagulans strains gave them daily, for example 2 billion CFU of Unique IS2 once a day for 4 weeks in adults with constipation, and they were generally well tolerated. Long-term daily use has been studied far less. Our Bacillus coagulans page covers that species' strains, uses and safety in detail.
References
- Cutting SM. Bacillus probiotics. Food Microbiology. 2011;28(2):214-220. doi:10.1016/j.fm.2010.03.007 ↩
- Colom J, Freitas D, Simon A, et al.. Presence and Germination of the Probiotic Bacillus subtilis DE111® in the Human Small Intestinal Tract: A Randomized, Crossover, Double-Blind, and Placebo-Controlled Study. Frontiers in Microbiology. 2021;12:715863. doi:10.3389/fmicb.2021.715863 ↩
- Ianiro G, Rizzatti G, Plomer M, et al.. Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2018;10(8):1074. doi:10.3390/nu10081074 ↩
- Maslennikov R, Gosteeva E, Ananeva V, et al.. Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome. Journal of Clinical Medicine. 2026;15(3):1152. doi:10.3390/jcm15031152 ↩
- Hill C, Guarner F, Reid G, et al.. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology. 2014;11(8):506-514. doi:10.1038/nrgastro.2014.66 ↩
- Xie P, Luo M, Deng X, Fan J, Xiong L. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Nutrients. 2023;15(17):3856. doi:10.3390/nu15173856 ↩
- Madempudi RS, Neelamraju J, Ahire JJ, Gupta SK, Shukla VK. Bacillus coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study. Probiotics and Antimicrobial Proteins. 2019;12(2):335-342. doi:10.1007/s12602-019-09542-9 ↩
- Abreu AT, Vázquez Frías R, Boggio Marzet C, et al.. Effectiveness of Bacillus clausii (O/C, N/R, SIN, T) in the Prevention of Antibiotic-Associated Diarrhea and Gastrointestinal Symptoms: A Systematic Review. Antibiotics. 2025;14(5):439. doi:10.3390/antibiotics14050439 ↩
- Williams N, Weir TL. Spore-Based Probiotic Bacillus subtilis: Current Applications in Humans and Future Perspectives. Fermentation. 2024;10(2):78. doi:10.3390/fermentation10020078 ↩
- Lefevre M, Racedo SM, Ripert G, et al.. Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study. Immunity & Ageing. 2015;12(1):24. doi:10.1186/s12979-015-0051-y ↩
- McFarlin BK, Henning AL, Bowman EM, Gary MA, Carbajal KM. Oral spore-based probiotic supplementation was associated with reduced incidence of post-prandial dietary endotoxin, triglycerides, and disease risk biomarkers. World Journal of Gastrointestinal Pathophysiology. 2017;8(3):117. doi:10.4291/wjgp.v8.i3.117 ↩
- Zou Q, Cai M, Hu Y, Ge C, Wang X, Duan R. Bacillus licheniformis bloodstream infections associated with oral probiotic administration: Two case reports. Indian Journal of Medical Microbiology. 2024;47:100485. doi:10.1016/j.ijmmb.2023.100485 ↩
- Zhu K, Hölzel CS, Cui Y, et al.. Probiotic Bacillus cereus Strains, a Potential Risk for Public Health in China. Frontiers in Microbiology. 2016;7:718. doi:10.3389/fmicb.2016.00718 ↩
- Seed Health. DS-01 Daily Synbiotic: Supplement Facts. Seed. 2026. Available at: https://seed.com/daily-synbiotic ↩
- Hong HA, Khaneja R, Tam NM, et al.. Bacillus subtilis isolated from the human gastrointestinal tract. Research in Microbiology. 2009;160(2):134-143. doi:10.1016/j.resmic.2008.11.002 ↩
- Navarra P, Milleri S, Perez III M, et al.. Kinetics of Intestinal Presence of Spores Following Oral Administration of Bacillus clausii Formulations: Three Single-Centre, Crossover, Randomised, Open-Label Studies. European Journal of Drug Metabolism and Pharmacokinetics. 2021;46(3):375-384. doi:10.1007/s13318-021-00676-2 ↩
- Tam NKM, Uyen NQ, Hong HA, et al.. The Intestinal Life Cycle of Bacillus subtilis and Close Relatives. Journal of Bacteriology. 2006;188(7):2692-2700. doi:10.1128/jb.188.7.2692-2700.2006 ↩
- Skrzydło-Radomańska B, Prozorow-Król B, Kurzeja-Mirosław A, et al.. The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome—A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial. Journal of Clinical Medicine. 2023;12(14):4838. doi:10.3390/jcm12144838 ↩
- Deng F, Chen Y, Sun T, et al.. Antimicrobial resistance, virulence characteristics and genotypes of Bacillus spp. from probiotic products of diverse origins. Food Research International. 2021;139:109949. doi:10.1016/j.foodres.2020.109949 ↩
- Wang X, Li S, Huo D, Li C, Zhang Q, Wang X. Case Series of Bacteremia Associated with Probiotic Use in Children after Cardiac Surgery, China. Emerging Infectious Diseases. 2026;32(1):28-33. doi:10.3201/eid3201.250298 ↩
- Hoa NT, Baccigalupi L, Huxham A, et al.. Characterization of Bacillus Species Used for Oral Bacteriotherapy and Bacterioprophylaxis of Gastrointestinal Disorders. Applied and Environmental Microbiology. 2000;66(12):5241-5247. doi:10.1128/aem.66.12.5241-5247.2000 ↩
- European Food Safety Authority (EFSA). Qualified presumption of safety (QPS). EFSA. 2026. Available at: https://www.efsa.europa.eu/en/applications/qps-assessment ↩